# SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia

> **NCT07344922** · PHASE3 · COMPLETED · sponsor: **Mansoura University** · enrollment: 100 (actual)

## Conditions studied

- Chronic Kidney Disease
- Anemia
- Cardiovascular Calcification

## Interventions

- **DRUG:** Dapagliflozin (10Mg Tab) along with standard medical therapy
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07344922
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07344922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07344922, "SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07344922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*